Kezar Historical Cash Flow
| KZR Stock | USD 0.69 0.01 1.47% |
Analysis of Kezar Life cash flow over time is an excellent tool to project Kezar Life Sciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 4.9 M or Begin Period Cash Flow of 33.6 M as it is a great indicator of Kezar Life ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Kezar Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Kezar Life Sciences is a good buy for the upcoming year.
Kezar |
About Kezar Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Kezar balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Kezar's non-liquid assets can be easily converted into cash.
Kezar Life Cash Flow Chart
Kezar Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Kezar Life Sciences Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Kezar Life's Investments are relatively stable compared to the past year. As of 06/03/2024, Stock Based Compensation is likely to grow to about 19 M, though Change In Cash is likely to grow to (4.7 M). Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Kezar Life Sciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Kezar Life operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Kezar Life's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Kezar Life Sciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. At this time, Kezar Life's Investments are relatively stable compared to the past year. As of 06/03/2024, Stock Based Compensation is likely to grow to about 19 M, though Change In Cash is likely to grow to (4.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 316K | 1.6M | 1.8M | 1.9M | Depreciation | 1.5M | 1.0M | 1.1M | 1.0M |
Kezar Life cash flow statement Correlations
Click cells to compare fundamentals
Kezar Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kezar Life cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 272K | 456K | 2.1M | 1.3M | 1.2M | 1.1M | |
| Investments | 21.0M | (56.3M) | (28.1M) | (89.8M) | 39.5M | 41.5M | |
| Change In Cash | (9.2M) | 6.3M | 41.7M | (22.4M) | (5.0M) | (4.7M) | |
| Stock Based Compensation | 4.0M | 4.9M | 7.6M | 14.0M | 18.1M | 19.0M | |
| Free Cash Flow | (30.5M) | (37.1M) | (42.8M) | (60.4M) | (83.5M) | (79.3M) | |
| Change In Working Capital | 881K | (2.0M) | 1.2M | (4.5M) | 4.7M | 4.9M | |
| Begin Period Cash Flow | 24.2M | 15.0M | 21.2M | 62.9M | 40.5M | 33.6M | |
| Total Cashflows From Investing Activities | 20.4M | (56.5M) | (28.4M) | (91.4M) | (82.3M) | (78.1M) | |
| Other Cashflows From Financing Activities | 272K | 99.6M | 19.1M | 127.9M | 638K | 606.1K | |
| Depreciation | 1.3M | 1.5M | 1.5M | 1.0M | 1.1M | 1.0M | |
| Capital Expenditures | 607K | 194K | 316K | 1.6M | 1.8M | 1.9M | |
| Total Cash From Operating Activities | (29.9M) | (36.9M) | (42.4M) | (58.8M) | (81.6M) | (77.6M) | |
| Change To Operating Activities | (1.3M) | (2.3M) | 9K | (6.3M) | (5.6M) | (5.4M) | |
| Net Income | (35.1M) | (41.7M) | (54.6M) | (68.2M) | (101.9M) | (96.8M) | |
| Total Cash From Financing Activities | 272K | 99.6M | 112.6M | 127.9M | 638K | 606.1K | |
| End Period Cash Flow | 15.0M | 21.2M | 62.9M | 40.5M | 35.5M | 35.7M | |
| Change To Netincome | 4.0M | 4.9M | 7.6M | 14.0M | 16.1M | 16.9M | |
| Change To Liabilities | 2.2M | 313K | 1.2M | 1.8M | 2.1M | 1.2M | |
| Other Non Cash Items | (979K) | 317K | 91K | (1.2M) | 2.7M | 2.8M | |
| Cash And Cash Equivalents Changes | (9.2M) | 6.2M | 41.7M | (22.4M) | (25.7M) | (24.4M) | |
| Cash Flows Other Operating | (1.3M) | (2.3M) | 9K | (6.3M) | (5.6M) | (5.4M) | |
| Issuance Of Capital Stock | 53.4M | 99.2M | 101.0M | 126.5M | (234K) | (222.3K) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Kezar Life Sciences information on this page should be used as a complementary analysis to other Kezar Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Kezar Stock analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Kezar Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kezar Life. If investors know Kezar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kezar Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 0.096 | Return On Assets (0.27) | Return On Equity (0.48) |
The market value of Kezar Life Sciences is measured differently than its book value, which is the value of Kezar that is recorded on the company's balance sheet. Investors also form their own opinion of Kezar Life's value that differs from its market value or its book value, called intrinsic value, which is Kezar Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kezar Life's market value can be influenced by many factors that don't directly affect Kezar Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kezar Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kezar Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kezar Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.